Rentschler Biopharma Names Robert Panting as VP Strategy

Rentschler Biopharma SE, a prominent CDMO for biopharmaceuticals, has appointed Robert Panting, Ph.D., as Vice President Global Client Program Management and Strategy. His new role involves leading the company's global strategy initiatives and client program management. Panting, a member of the Global Leadership Team, will report directly to the CEO.

CEO Benedikt von Braunmühl emphasizes the need for a strong strategic framework due to evolving industry complexities. Panting's experience in managing complex projects aligns with their goals. His focus will be on developing a unified strategic roadmap, with short-, mid-, and long-term priorities.

Panting, who joined the company in 2021, previously led Rentschler ATMP Ltd. His background includes a tenure at Fujifilm Diosynth Biotechnologies, where he gained extensive management experience.